Stock Opioid
Sort by
52 items
-
MarketWatch - Business
Bristol-Myers Squibb stock jumps on schizophrenia drug approval
Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.Yesterday -
MarketWatch - Business
Costco’s stock slips as quarterly sales come up short and fee hike won’t immediately lift revenue
Shares of Costco Wholesale Corp. slipped after hours, after the membership warehouse retailer reported sales trends that came up shy of Wall Street’s estimates.Yesterday -
MarketWatch - Business
These key indicators say the S&P 500 will continue its hot streak
The S&P 500 looks solid, while new highs on the NYSE continue to swamp new lows.Yesterday -
CNBC - Business
How we're thinking about 7 portfolio stocks with ties to OpenAI after its latest shakeup
Less than a year after CEO Sam Altman's brief ouster rattled OpenAI, the board is mulling a for-profit structure, and three high-profile employees are leaving.Yesterday